Andreas FALK (Austria)

Andreas FALK (Austria)

PLACE OF WORK:

 

BioNanoNet Forschungsgesellschaft mbH

Elisabethstraße 20/2, 8010 Graz

 

 

CONTACT

 

Phone : +43 699 15526601

 

Email : Andreas.Falk (at) bionanonet.at

 

COST ROLE : NanoSafety-Aspects, Nanotoxicity

Description of the Organisations and PI

 

BioNanoNet Forschungsgesellschaft mbH (BNN) is an Austrian scientific network that specializes in the Key Enabling Technologies nanotechnology and biotechnology on a national and international basis, with the emphasis on (1) nanotoxicology, (2) sensortechnologies, as well as (3) health, safety, (nano-)medicine and additionally supports projects in coordination, management, dissemination and communication. BioNanoNet is a European key player in the field of nanosafety, specialised in developing nano-safety-by-design strategies together with researchers and industry.

Andreas Falk, (male), is CEO of BioNanoNet Forschungsgesellschaft mbH and he was/is part of several completed (i.e., NanoProdEx, NANOFORCE, NanoDiode, NANoREG) and ongoing projects (i.e., SPIDIMAN, R2R Biofluidics, SeeingNano, Hi-Response, INSPIRED, NANOSOLUTIONS, ProSafe, EC4SafeNano) in the thematic field of nanotechnology, nanotoxicology, nano-health and sensor solutions. He coordinates the EURO-NanoTox (European Center for Nanotoxicology) which is focusing on fostering the communication between experts in the field of nanotoxicology and nano-safety. He represents Austria, BioNanoNet and its members within several national and international working groups (NanoSafetyCluster safe-by-design working group, European Technology Platforms Nanomedicine and SusChem, NANOfutures, COST-Actions TD1204, CM1403, etc.). He holds a degree in biomedical science (1999) and business administration (2011), combining two major scientific and economic fields, which are a valuable basis in addressing nano-related safety and business aspects as well as project management.

 

Description and scientific profiles of the group

 

BNN coordinates the Austrian NanoSafety-Research-community and therefore has access to key technologies for nano-safety assessment along the value chain (e.g., nano-safety-by-design strategies). BNN provides communication and dissemination services; its newsletters reaches “nano-professionals” worldwide. Standardisation and regulatory aspects of nanotechnology (e.g. safety data sheets, exposure scenarios, REACH context, etc.) is key topics in the research of BNN.

 

The core competencies of the scientific team of BNN are

  • the development of customized nano-safety strategies, elaborated together with the technical developers, and
  • taking into consideration specific needs of your company as well as
  • guiding the implementation of safe-by-design concept.

Furthermore, BNN supports in project management and project dissemination activities based on the multi-year experience with national and European projects in the management team of BioNanoNet.

Most significant recently published papers:

 

  1. Falk A., Schimpel C., Haase A., Hazebrouck B., Fito López C., Prina-Mello A., Savolainen K., Sips A., Lopez de Ipiña J. M., Lynch I., Charitidis C., Visser G., 2016, “Closer to the market”-Roadmap (CTTM), NanoSafety Cluster 2016, p.1-43.

http://www.nanosafetycluster.eu/uploads/files/pdf/CTTM_NSC_Roadmap_final_for_NSC.PDF

  1. Schimpel C., Rinner B., Absenger-Novak M., Meindl C., Fröhlich E., Falk A., Zimmer A., Roblegg E., 2015, "A novel In Vitro Model for Studying Nanoparticle Interactions with the Small Intestine", EURO-NanoTox-LETTERS, DOI: 10.1515/entl-2015-0001 EJE.
  2. Malka I., Jurewicz M., Swiderska-Sroda A., Sobczyk J., Lojkowski W., Hartl S., Falk A., Guidelines for Safe Operation with Nanomaterials, book chapter in: The Nano-Micro Interface: Bridging Micro and Nano Worlds, Fecht H.-J., Werner M., Van de Voorde M., 2 Volume Set, 2nd Edition 2014, p635-665. http://eu.wiley.com/WileyCDA/WileyTitle/productCd-3527336338.html
  3. Falk A., Hartl S., Sinner F., 2013, „Regulation and Safety Implementation of Nanotechnology for Chemical Enterprises in the Central Europe Space”, J. Phys.: Conf. Ser. 429 012068, DOI: 10.1088/1742-6596/429/1/012068.
  4. Roblegg E., Falk A., Froehlich E., Zimmer A., Sinner F., 2011, European Center for Nanotoxicology EURO-NanoTox – An Austrian Activity, Academy of Science Malaysia Journal, 5 (1). http://asmic.akademisains.gov.my/download/journal/ASMSJ_Vol5_No1.pdf

Related research grants:

 

National ongoing projects:

  • “EURO-NanoTox – European Centre of Nanotoxicology”; The European Centre for Nanotoxicology

 

European ongoing projects:

  • “NANoREG- A common European approach to the regulatory testing of nanomaterials”, EU-FP7-NMP 2012-LARGE-6.
  • “NanoDiode - Developing Innovative Outreach and Dialogue on responsible nanotechnologies in EU civil society”, EU-FP7-NMP 2013-CSA-07.
  • “SeeingNano - Developing and Enabling Nanotechnology Awareness-Building through the Creation and Exchange of enhanced Communication and Visualisation Tools and Guidance for ‘Seeing at the Nanoscale”, EU-H2020-NMP 2014-CSA-31.
  • “Hi-Response – Innovative High Resolution Electro-Static printing of Multifunctional Materials”, EU-H2020-NMP-PILOTS 2014-04.
  • “R2R-Biofluidics – Large Scale Micro- and Nanofabrication Technologies for Bioanalytical Devices Based on R2R Imprinting”, EU-H2020-NMP-PILOTS 2014-04.
  • “Inspired – Industrial Scale Production of Innovative nanomaterials for printed devices”, EU-H2020-NMP-PILOTS 2014-05.
  • „NanoGenTools – Developing and implementation of a new generation of nanosafety assessment tools“; H2020-MSCA-RISE-2015.

 

 

 

EUROPEAN UPCONVERSION NETWORK

COST Action CM1403 (2014-2018)

Chair: dr Hans Gorris (University of Regensburg, Germany)

Vice-Chair: prof.Tero Soukka (University of Turku, Finland)

COST Science Officer: Dr. Lucia Forzi (Bruseels, Belgium)

STSMs Manager: dr hab. Artur Bednarkiewicz (PAS & WCB EIT+, Poland)

CONTACT

info @ ucnp.eu

http://www.cost.eu/COST_Actions/cmst/CM1403

web page : Artur Bednarkiewicz Copyright © 2016 All Rights Reserved